Back
FlexShares Real Assets Allocation ETF Vs. Sarepta Therapeutics Industry Stock Comparison
Sell
40
ASET
FlexShares Real Assets Allocation ETF
Last Price:
32.42
Seasonality Move:
2.11%
Sell
36
SRPT
Sarepta Therapeutics
Last Price:
124.65
Seasonality Move:
-1.39%
Sell
40
FlexShares Real Assets Allocation ETF (ASET)
is a Sell
Is FlexShares Real Assets Allocation ETF a Buy, Sell or Hold?
- The current FlexShares Real Assets Allocation ETF [ASET] share price is $32.70. The Score for ASET is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- ASET is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
36
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $124.53. The Score for SRPT is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
- SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ASET Stock Price Chart
What is FlexShares Real Assets Allocation ETF's stock price today?
-
The FlexShares Real Assets Allocation ETF share price today is $32.70
The current trend is moderately bullish and ASET is experiencing selling pressure, which indicates risk of future bearish movement.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $124.53
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight selling pressure.
ASET Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.34 | Buy |
Relative Strength Index (14 RSI): | 63.24 | Buy |
Chaikin Money Flow: | -1244 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (31.75 - 32.53) | Buy |
Bollinger Bands (100): | (30.47 - 31.89) | Buy |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.18 | Sell |
Relative Strength Index (14 RSI): | 35.54 | Sell |
Chaikin Money Flow: | -49995 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (124.27 - 135.95) | Sell |
Bollinger Bands (100): | (123.89 - 147.49) | Sell |
ASET Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 32.58 | Buy |
20-day SMA: | 32.18 | Buy |
50-day SMA: | 31.53 | Buy |
200-day SMA: | 30.71 | Buy |
8-day EMA: | 32.56 | Buy |
20-day EMA: | 32.25 | Buy |
50-day EMA: | 31.73 | Buy |
200-day EMA: | 30.82 | Buy |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 125.45 | Sell |
20-day SMA: | 127.75 | Sell |
50-day SMA: | 135.2 | Sell |
200-day SMA: | 127.53 | Sell |
8-day EMA: | 125.39 | Sell |
20-day EMA: | 128.04 | Sell |
50-day EMA: | 132.59 | Sell |
200-day EMA: | 128.64 | Sell |
FlexShares Real Assets Allocation ETF Earnings Growth & ASET Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.96 per share, an increase next quarter of $2.81 per share, an increase this year of $4.41 per share, and an increase next year of $9.14 per share.
FlexShares Real Assets Allocation ETF Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |